Switch to Rosuvastatin Plus Ezetimibe From Statin Monotherapy to Achieve Target LDL-Cholesterol Goal: A Multi-Center, Open-Label, Single-Arm Trial

Switch to Rosuvastatin Plus Ezetimibe From Statin Monotherapy to Achieve Target LDL-Cholesterol Goal: A Multi-Center, Open-Label, Single-Arm Trial

Saved in:

Bibliographic Details
Main Authors:	Hong-Kyun Park, Jong-Ho Park, Hee-Kwon Park, Kyusik Kang, Keun-Hwa Jung, Beom Joon Kim, Jin-Man Jung, Young Seo Kim, Yong-Seok Lee, Hyo Suk Nam, Yeonju Yu, Juneyoung Lee, Keun-Sik Hong
Format:	Article
Language:	English
Published:	Korean Stroke Society 2025-05-01
Series:	Journal of Stroke
Online Access:	http://j-stroke.org/upload/pdf/jos-2024-05015.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comparison of rosuvastatin 10 mg plus ezetimibe versus rosuvastatin 20 mg in atherosclerotic cardiovascular disease and type 2 diabetes
by: Hyo-In Choi, et al.
Published: (2025-05-01)

Multiply doses of FDC of rosuvastatin and ezetimibe versus rosuvastatin monotherapy in Chinese patients with hypercholesterolemia (ROSE-CH): multicenter, randomized-controlled trial
by: Xianyou Ji, et al.
Published: (2025-07-01)

Efficacy and safety of moderate-intensity rosuvastatin plus ezetimibe versus high-intensity rosuvastatin monotherapy in the treatment of composite cardiovascular events with hypercholesterolemia: A meta-analysis.
by: Lingyan Liu, et al.
Published: (2024-01-01)

Efficacy and safety of moderate-intensity rosuvastatin plus ezetimibe versus high-intensity rosuvastatin monotherapy in the treatment of composite cardiovascular events with hypercholesterolemia: A meta-analysis
by: Lingyan Liu, et al.
Published: (2024-01-01)

Lipid profile and safety of rosuvastatin monotherapy versus rosuvastatin plus ezetimibe in high risk coronary artery disease: a systematic review and meta-analysis of randomized controlled trials
by: Arga Setyo Adji, et al.
Published: (2025-06-01)

NEW OPPORTUNITIES FOR PREVENTIVE THERAPY WITH STATINS DURING CHD PATIENTS’ REHABILITATION, WITH CLINICAL SIGNS OF MODERATE CHF: EFFECTIVENESS OF ROSUVASTATIN AND EZETIMIBE
by: N. I. Tarasov, et al.
Published: (2016-06-01)

The impact of statin-ezetimibe combination therapy versus statin monotherapy on coronary plaque regression in patients with acute coronary syndrome: a meta-analysis
by: Yusra Pintaningrum, et al.
Published: (2024-07-01)

Efficacy and safety of statins, ezetimibe, and fibrates monotherapy or combination therapy for hyperlipidemia: a systematic review and network meta-analysis
by: Shujie Zhang, et al.
Published: (2025-06-01)

Population Pharmacokinetics and Pharmacodynamics with Enterohepatic Recirculation of Co-Medication of Rosuvastatin and Ezetimibe
by: An H, et al.
Published: (2025-06-01)

Study Design and Protocol for a Randomized Controlled Trial to Assess Long-Term Efficacy and Safety of a Triple Combination of Ezetimibe, Fenofibrate, and Moderate-Intensity Statin in Patients with Type 2 Diabetes and Modifiable Cardiovascular Risk Factors (ENSEMBLE)
by: Nam Hoon Kim, et al.
Published: (2024-10-01)

Combination of statin and ezetimibe in the post-infarction period
by: Valentin E. Oleynikov, et al.
Published: (2024-12-01)

The clinical effectiveness and safety of low/moderate-intensity statins & ezetimibe combination therapy vs. high-intensity statin monotherapy: a systematic review and meta-analysis
by: Pishoy Sydhom, et al.
Published: (2024-11-01)

Effectiveness of fixed-dose combination of rosuvastatin and ezetimibe in heterozygous familial hypercholesterolemia from the RENAISSANCE registry
by: I. A. Alekseeva, et al.
Published: (2025-08-01)

ROSUVASTATIN - THE MOST POTENT STATIN IN CARDIOVASCULAR DISEASE PREVENTION
by: A. E. Semenova, et al.
Published: (2018-06-01)

LIPID-LOWERING EFFICACY OF ROSUVASTATIN COMPARED WITH OTHER STATINS
by: A. N. Meshkov
Published: (2015-12-01)

Treatment adherence, persistence, and effectiveness of fixed dose combination versus free combination therapy of rosuvastatin–ezetimibe as a lipid-lowering therapy
by: Mihail Samnaliev, et al.
Published: (2025-05-01)

Clinical Outcomes of Ezetimibe Plus Statins in Patients With Lower Extremity Artery Disease
by: Yoshihiro Iwasaki, MD, PhD, et al.
Published: (2025-09-01)

Protocol for a systematic review and meta-analysis of the combination of ezetimibe and statins for hyperlipidemia
by: Tianfu Yang, et al.
Published: (2024-01-01)

Protocol for a systematic review and meta-analysis of the combination of ezetimibe and statins for hyperlipidemia.
by: Tianfu Yang, et al.
Published: (2024-01-01)

Behavioral patterns of Chum salmon (Oncorhynchus keta) during spawning migration across the coastal water-river continuum in Northeastern Korea
by: Beom-Sik Kim, et al.
Published: (2025-04-01)

Incidence, Predictors, and Management of Femoral Vascular Complications Following Catheter Ablation for Atrial Fibrillation: A Systematic Duplex Ultrasound Study
by: Hyo Jin Lee, et al.
Published: (2025-01-01)

A Yellowish Granular Lesion in the Esophagus
by: Seong Keun Lee, et al.
Published: (2018-03-01)

NIR-Guided Coating Optimization of Omega-3 Fatty Acid Mini Soft Capsules with Pitavastatin and Ezetimibe
by: Hye-Ri Han, et al.
Published: (2024-10-01)

Effect of different statins and EZETIMIBE/SIMVASTATIN on cardiovascular disease in patients with chronic kidney disease
by: ZHANG Xue-qing, et al.
Published: (2018-01-01)

The effectiveness of Rosuvastatin in controlling LDL-C and non-HDL-C levels in hypertensive patients with or without diabetes mellitus
by: To Anh Tan Le, et al.
Published: (2025-06-01)

ESCADRA: a randomised study. Part I: lipid-lowering effectiveness, safety and tolerability of ezetimibe, initial doses of original statins, and the combination of ezetimibe with initial doses of statins in patients with coronary heart disease and hyperlipidemia
by: M. Yu. Zubareva, et al.
Published: (2010-12-01)

Ineffective statin monotherapy: alternative therapeutic strategy
by: I. V. Sergienko
Published: (2011-08-01)

Efficacy and safety of combination therapy Ezetimibe 10/rosuvastatin 40 in Egyptian patients at very high risk of atherosclerotic cardiovascular disease
by: Mohamed Sobhy, et al.
Published: (2025-06-01)

Statins' protective effects on focal epilepsy are independent of LDL‐C
by: Zhen Sun, et al.
Published: (2025-04-01)

Addition of Bempedoic Acid to Statin–Ezetimibe versus Statin Titration in Patients with High Cardiovascular Risk: A Single-Centre Prospective Study
by: Giuseppe Marazzi, et al.
Published: (2024-09-01)

Impact of COVID-19 on human immunodeficiency virus tests, new diagnoses, and healthcare visits in the Republic of Korea: a retrospective study from 2016 to 2021
by: Yeonju Kim, et al.
Published: (2024-08-01)

Triple Non-Statin Therapy with Ezetimibe, Inclisiran, and Bempedoic Acid in Patients with Genetically Confirmed Statin-Induced Rhabdomyolysis: A Dual Case Report
by: Jozef Dodulík, et al.
Published: (2025-05-01)

Tailored intervention improves statin adherence and reduces LDL-cholesterol levels
by: Wenny Putri Nilamsari, et al.
Published: (2025-08-01)

LDL cholesterolemia as a novel risk factor for radiographic progression of rheumatoid arthritis: a single-center prospective study.
by: Yune-Jung Park, et al.
Published: (2013-01-01)

Key Environmental Drivers of Summer Phytoplankton Size Class Variability and Decadal Trends in the Northern East China Sea
by: Jung-Woo Park, et al.
Published: (2025-06-01)

Effect of atorvastatin and rosuvastatin on the PCSK9 blood concentration in statin-naive patients with atherosclerosis
by: A. Yu. Filatova, et al.
Published: (2019-06-01)

Study Design and Rationale of a Randomized Trial Comparing Aspirin–Sarpogrelate Combination Therapy with Aspirin Monotherapy: Effects on Blood Viscosity and Microcirculation in Cardiovascular Patients
by: Yuran Ahn, et al.
Published: (2025-05-01)

Statin Monotherapy Not Inferior to Aspirin or Combined Aspirin and Statins Reducing the Incidences of Cirrhosis, HCC, and Mortality in MAFLD/MASH Patients: A Population Cohort Study
by: Lee CH, et al.
Published: (2024-12-01)

Ionospheric TEC and ROT Analysis with Signal Combinations of QZSS Satellites in the Korean Peninsula
by: Byung-Kyu Choi, et al.
Published: (2025-06-01)

Does statin have a chemopreventive effect in patients with ulcerative colitis?
by: Yoon Suk Jung
Published: (2025-04-01)